Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NexImmune, Inc. (NEXI)
|
Add to portfolio |
|
|
|
| Price: |
$4.46
| | Metrics |
| OS: |
26.1
|
M
| |
|
|
| Market cap: |
$116
|
M
| |
|
|
|
Net cash:
|
$16.3
|
M
| |
$0.62
|
per share
|
|
EV:
|
$100
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($61.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 15.2 | 8.1 |
| Revenue growth | | -100.0% | 86.5% | |
| Cost of goods sold | 0.0 | 0.0 | 20.9 | 13.2 |
| Gross profit | 0.0 | 0.0 | -5.7 | -5.1 |
| Gross margin | | | -37.7% | -62.8% |
| Research and development | 37.5 | 17.8 | | |
| General and administrative | 15.8 | 10.0 | 5.7 | 5.2 |
| EBIT | -53.3 | -27.9 | -20.9 | -13.2 |
| EBIT margin | | | -137.7% | -162.8% |
| Pre-tax income | -50.9 | -29.9 | -20.5 | -12.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -51.3 | -33.1 | -20.5 | -12.8 |
| Net margin | | | -135.4% | -157.7% |
| |
| Diluted EPS | ($2.54) | ($26.42) | ($16.56) | ($0.01) |
| Shares outstanding (diluted) | 20.2 | 1.3 | 1.2 | 1,122.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|